PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RedLine Public Relations

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint - Astell, autoclave and steriliser manufacturer, launch new Duaclave range
Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint

 

NewswireToday - /newswire/ - Princes Risborough, Bucks, United Kingdom, 2010/02/22 - Astell, autoclave and steriliser manufacturer, launch new Duaclave range.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Astell, the leading autoclave and steriliser manufacturers, have solved the eternal problem of how to double your laboratory’s autoclave capacity without increasing the equipment footprint. Their new Duaclave range combines two identical chambers, one directly above the other within one frame.

The two chambers come equipped with all the features that Astell users have come to expect like delayed start, allowing sterilisation to take place overnight, Holdwarm capability to maintain the autoclave at a pre-set temperature after sterilisation until required and data archiving to ensure that all cycle details are automatically recorded and saved.

The two chambers are fully independent and each has its own Logi control system accessed via a full colour, icon-driven touch screen with password protected security. This means that, for example, while one chamber may be processing fluids, the other can either be sitting idle or perhaps completing a discard load.

The range includes both electrically heated and direct steam heated models, and options include load sensed process timing, assisted cooling and assisted cooling.

As with all Astell autoclaves and sterilisers, the Duaclave range is CE marked and manufactured to comply with the Pressure Equipment Directive PD97/23/EC, the Medical Devices Directive MDD 93/42/EEC and all other applicable UK and international standards. Full IQ and OQ documentation is available for all models.

Astell Duaclave autoclaves are available in 33, 43, 63, 120 and 153 litre chamber sizes to suit most laboratory applications including sterilisation of reagents and media, glassware, laboratory instruments and discard.

Contact Astell (astell.com) for further information on sterilisation solutions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RedLine Public Relations

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jane Wardrop - Redline-PR.co.uk 
+44(0)18 4427 3407 sales[.]astell.com www.astell.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RedLine Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RedLine Public Relations / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  SKS Media | SKS Associates Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)